LeonaBio (LONA) Consolidated Net Income (2019 - 2026)

LeonaBio (LONA) has 8 years of Consolidated Net Income data on file, last reported at -$17.2 million in Q1 2026.

• Consolidated Net Income for Q1 2026 came in at -$17.2 million, down 80.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$109.9 million (down 32.86% YoY), and the FY2025 annual result was -$105.6 million, down 351933.33% from the prior year.
• Consolidated Net Income grew to -$17.2 million in Q1 2026 per LONA's latest filing, from -$78.6 million in the prior quarter.
• Over five years, Consolidated Net Income peaked at -$6.9 million in Q3 2025 and troughed at -$78.6 million in Q4 2025.
• A 5-year average of -$26.5 million and a median of -$27.7 million in 2024 frame the typical range for Consolidated Net Income.
• On a YoY basis, Consolidated Net Income climbed as much as 76.79% in 2025 and fell as far as 404.72% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at -$32.9 million in 2022, then grew by 11.88% to -$29.0 million in 2023, then soared by 46.35% to -$15.6 million in 2024, then slumped by 404.72% to -$78.6 million in 2025, then soared by 78.09% to -$17.2 million in 2026.
• Business Quant data shows LONA's Consolidated Net Income at -$17.2 million in Q1 2026, -$78.6 million in Q4 2025, and -$6.9 million in Q3 2025.